Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata Medical Dialogues Bureau19 March 2020 12:56 PM ISTBaricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
